Tectonic Therapeutic, Inc. (TECX)
NASDAQ: TECX · Real-Time Price · USD
27.85
+0.44 (1.61%)
Mar 5, 2026, 4:00 PM EST - Market closed
Tectonic Therapeutic Market Cap
Tectonic Therapeutic has a market cap or net worth of $522.93 million as of March 6, 2026. Its market cap has increased by 12.56% in one year.
Market Cap
522.93M
Enterprise Value
270.41M
1-Year Change
12.56%
Ranking
Category
Stock Price
$27.85
Market Cap Chart
Since June 21, 2024, Tectonic Therapeutic's market cap has increased from $250.63M to $522.93M, an increase of 108.65%. That is a compound annual growth rate of 53.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 5, 2026 | 522.93M | 33.94% |
| Dec 31, 2025 | 390.42M | -42.68% |
| Dec 31, 2024 | 681.13M | 171.77% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rigel Pharmaceuticals | 545.33M |
| Fulcrum Therapeutics | 543.46M |
| Verastem | 540.19M |
| Forte Biosciences | 539.94M |
| Allogene Therapeutics | 519.13M |
| ADC Therapeutics | 519.05M |
| Neumora Therapeutics | 509.82M |
| Prothena Corporation | 509.26M |